Senti Biosciences divests Midco and Opco to ST NewCo

By Public Technologies
  • Senti Biosciences Holdings divested Midco and operating subsidiary Senti Biosciences to ST NewCo, transferring substantially all its existing business and pipeline.
  • The company retained its Rett Syndrome and TIL programs, supported by intellectual property and contracts transferred before closing.
  • Merger consideration consists of contingent value rights worth up to $60 million, payable upon SENTI-202 milestones achieved within seven years.
  • Pro forma estimates show a $6.65 million disposal loss, incorporating the expected exchange of $16 million of Notes at $0.342 per share.
  • ST NewCo purchased $2.5 million of common stock at closing to fund continuing operations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senti Biosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-040772), on October 26, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.